
CRN challenges FDA chief's criticism of dietary supplements
CRN calls for a science-driven FDA strategy, highlighting extensive research backing dietary supplements.
CRN calls for a science-driven FDA strategy, highlighting extensive research backing dietary supplements.
PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models.
The continuing resolution to fund the government failed a House vote, 235 to 174.
Aetna expands app functionality to better connect with Spanish-speaking members
DOJ’s intervention follows the complaint originally filed by Baron & Budd in 2019.
Barnes brings extensive health care management experience to the company.
But Congress must ignore big insurance and the PBM lobby’s last-ditch effort to scuttle reforms and pass the continuing resolution.
NACDS is hailing PBM reforms contained in the 118th Congress’ culminating legislative package, and is urging the U.S. House of Representatives and U.S. Senate to advance this continuing resolution to President Biden’s desk for signature.
Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).
"We are honored to be recognized by Forbes as one of the Best Employers for Tech Workers and for our unparalleled customer service specifically in pharmacy."
Quincy Bioscience, the dietary supplement maker, must stop making specific advertising claims deemed deceptive.
With the growing demand for PBM reform, Trump has stated that action must be taken.
Pharmacy leaders demand Congress address PBM practices.
Walgreens joined independent pharmacies at Monday’s Arkansas Insurance and Commerce Senate hearing.
NACDS: “As the continuing resolution is finalized, Americans and their pharmacies are watching and waiting for real PBM reform now to lower drug costs and to protect pharmacy access”.
The Walgreens Patient Advisory Board will work with the Walgreens Clinical Trials team to provide insights aimed at increasing representation in clinical trials.